[HTML][HTML] Omicron variant (B. 1.1. 529) and its sublineages: What do we know so far amid the emergence of recombinant variants of SARS-CoV-2?

M Dhawan, ARA Saied, S Mitra, FA Alhumaydhi… - Biomedicine & …, 2022 - Elsevier
Since the start of the COVID-19 pandemic, numerous variants of SARS-CoV-2 have been
reported worldwide. The advent of variants of concern (VOCs) raises severe concerns amid …

mRNA vaccines: The future of prevention of viral infections?

P Rzymski, A Szuster‐Ciesielska… - Journal of medical …, 2023 - Wiley Online Library
Messenger RNA (mRNA) vaccines against COVID‐19 are the first authorized biological
preparations developed using this platform. During the pandemic, their administration has …

Building genomic capacity for precision health in Africa

A Olono, V Mitesser, A Happi, C Happi - Nature Medicine, 2024 - nature.com
The African continent is poised to have a pivotal role in the global population landscape,
with the United Nations projecting a population of 2.5 billion (more than 25% of the global …

Further analysis of tuberculosis in eight high-burden countries based on the Global Burden of Disease Study 2021 data

H Lv, L Wang, X Zhang, C Dang, F Liu, X Zhang… - Infectious Diseases of …, 2024 - Springer
Backgrounds Most significant findings from the Global Tuberculosis (TB) Report 2023
indicate that India, Indonesia, China, the Philippines, Pakistan, Nigeria, Bangladesh, and the …

Impact of the COVID-19 pandemic on malaria control in Africa: A preliminary analysis

L Gao, Q Shi, Z Liu, Z Li, X Dong - Tropical Medicine and Infectious …, 2023 - mdpi.com
Malaria remains a significant public health concern in Africa, and the emerging coronavirus
disease 2019 (COVID-19) pandemic may have negatively impacted malaria control. Here …

Process automation and control strategy by quality-by-design in total continuous mRNA manufacturing platforms

A Schmidt, H Helgers, FL Vetter, S Zobel-Roos… - Processes, 2022 - mdpi.com
Vaccine supply has a bottleneck in manufacturing capacity due to operation personnel and
chemicals needed. Assessment of existing mRNA (messenger ribonucleic acid) vaccine …

Variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and vaccine effectiveness

SRV Tulimilli, S Dallavalasa, CG Basavaraju… - Vaccines, 2022 - mdpi.com
The incidence and death toll due to SARS-CoV-2 infection varied time-to-time; and
depended on several factors, including severity (viral load), immune status, age, gender …

Addressing the re-emergence and resurgence of vaccine-preventable diseases in Africa: A health equity perspective

AF Lubanga, AN Bwanali, M Kangoma… - Human Vaccines & …, 2024 - Taylor & Francis
Vaccination is one of the greatest public health achievements of the 20th century, with a
tremendous impact in the prevention and control of diseases. However, the recent …

Building Africa's first mRNA vaccine facility

ARA Saied - The Lancet, 2023 - thelancet.com
J Gen Intern Med 2021; 36: 2146. it is paramount for health-care professionals to be familiar
with this matter, both in terms of local and international regulations, as well as its medical …

A Review of the Important Weapons against Antimicrobial Resistance in Sub-Saharan Africa

N Gahamanyi, T Umuhoza, SI Saeed, LN Mayigane… - Applied …, 2023 - mdpi.com
Antimicrobial resistance (AMR) is one of the top 10 global health threats facing humanity,
and the sub-Saharan Africa (SSA) is among the heavily affected regions due to its weak …